Molecular diagnosis refers to the technique of using molecular biological methods to detect changes in the structure or expression level of genetic material in patients to make a diagnosis.

On June 29, Merck announced an investment of approximately 70 million euros to expand its Nantong Life Science Center in the heart of the Yangtze River Delta region.

POCT industry started late in China, the overall market size is still small currently, and the penetration rate in hospitals and other terminal sites is low, so there is a huge potential development space. Qianzhan Institute predicts that from 2022-2027, the Chinese POCT market will rise by about 9% CAGR to about 18 billion yuan in 2027.

Recently, the Chinese Center for Disease Control and Prevention (CDC) issued a Notice on the public consultation of 2 standards.

On June 9, a launching ceremony was held for the Stago Medical Device Factory. On the same day, the opening ceremony of DiaSorin’s Baoshan factory was held.

From March 15, China has officially announced the resumption of all kinds of visas, including tourist visas (L Visa), and visa-free policies have been reinstated.

Recently, the General Office of the State Council communicated Measures of Ministry of Commerce and the Ministry of Science and technology (MOST) for Further Encouraging Foreign Investment in Establishing Research and Development (R&D) Centers in China.

Blood gas diagnosis mainly involves measuring the pH value, pCO2, pO2, and other gases dissolved in human blood to understand the body's respiratory function and acid-base balance status.

China's foreign ministry said on Tuesday that all inbound travellers will only need to show COVID-19 antigen tests result taken within 48 hours before boarding flights starting April 29, dropping the PCR test requirement.

On October 17, 2020, the 22nd meeting of the Standing Committee of the 13th National People's Congress voted to adopt the Biosafety Law, which will come into force on April 15, 2021.